Laxoberon

Sodium picosulfate, the active ingredient in Laxoberon, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic procedures such as colonoscopy in adult patients, providing effective colonic cleansing.

GNH USA supplies Laxoberon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across multiple markets. The company ensures product integrity through controlled manufacturing, rigorous testing, and secure distribution channels, facilitating reliable access for healthcare providers globally.

Laxoberon, a stimulant laxative, acts on the colon to promote bowel movements and is used in the following clinical situations: - Constipation: Relieves infrequent or difficult bowel movements by stimulating colonic peristalsis. - Colonoscopy preparation: Provides thorough bowel cleansing to enable clear visualization during colonoscopic examination. - Sigmoidoscopy preparation: Facilitates effective bowel emptying prior to flexible sigmoidoscopy procedures.

Laxoberon may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Abdominal cramps: Cramping discomfort in the lower abdomen. - Diarrhea: Loose, watery stools after dosing. - Nausea: Feeling of queasiness without vomiting.

Serious or Rare Side Effects: - Severe dehydration: Marked loss of body fluids requiring medical attention. - Electrolyte disturbances: Significant hyponatremia or hypokalemia. - Colonic perforation: Rare but life‑threatening tear in the colon wall.

When using Laxoberon, several precautions should be observed to ensure safe and effective therapy. - Assess bowel function: Confirm presence of constipation before initiating therapy. - Medical supervision: Use under direction of a healthcare professional, especially for bowel preparation. - Avoid acute abdominal conditions: Do not use in cases of intestinal obstruction, perforation, or acute abdomen. - Monitor fluid and electrolyte balance: Ensure adequate hydration and consider electrolyte status during treatment. - Do not exceed recommended dose: Follow prescriber instructions and avoid repeated dosing without guidance. - Store at ambient temperature: Keep in original packaging, protect from moisture and heat.

Laxoberon can interact with other medicines, and interactions are classified by their clinical significance.

Major Interactions (Avoid): - Anticholinergic agents: May reduce laxative efficacy. - Opioid analgesics: Counteract stimulant effect on colonic motility. - Mineral oil: Can interfere with drug absorption.

Moderate Interactions (Monitor Closely): - Diuretics: Increased risk of electrolyte imbalance due to fluid loss. - Antihypertensives: Potential for enhanced hypotensive effect from dehydration. - Antacids: May alter intestinal pH and affect drug activation.